← back to search

Ronald D. Brown

University of Rochester Medical Center · US
Area of research
Endocrinology, Diabetes and Metabolism · Molecular Biology
Research interest
Research focused on Mutant and Cancer research, with related work in Melanoma, Vemurafenib, KRAS. Notable publications include 'EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib', 'Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models', and 'TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF- Mutant Melanoma'.
h-index
—
citations
1,540
works
3
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in <i>BRAF-</i> Mutant Melanoma
Science Translational Medicine 2013cited by 137position: middledoi
EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of <i>BRAF</i> -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
Cancer Discovery 2012cited by 1,025position: middledoi
Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models
Cancer Cell 2012cited by 378position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ryan B. Corcoran · Harvard University3 papers (2012–2013)Jeffrey A. Engelman · Novartis (Germany)3 papers (2012–2013)Mari Mino–Kenudson · Harvard University3 papers (2012–2013)Jeffrey Settleman · Enzo Life Sciences (United States)3 papers (2012–2013)Dora Dias‐Santagata · University of Colorado Denver2 papers (2012–2012)Adriano Piris · University of Arkansas for Medical Sciences2 papers (2012–2013)Keith T. Flaherty · Boston Medical Center2 papers (2012–2013)Jennifer A. Wargo · The University of Texas MD Anderson Cancer Center2 papers (2012–2013)Anthony C. Faber · KU Leuven2 papers (2012–2013)Erin M. Coffee · KU Leuven2 papers (2012–2012)Kenneth E. Hung · KU Leuven2 papers (2012–2012)Aaron N. Hata · Harvard University2 papers (2012–2013)Hiromichi Ebi · Nippon Kayaku (Japan)2 papers (2012–2012)Toshi Shioda · Center for Cancer Research1 papers (2012–2012)Youngchul Song · Novartis (Switzerland)1 papers (2012–2012)Travis J. Cohoon · University of California, Irvine1 papers (2012–2012)Anurag Singh · Center for Cancer Research1 papers (2012–2012)Kwok‐Kin Wong · NYU Langone Health1 papers (2012–2012)S. Michael Rothenberg · Pfizer (United States)1 papers (2013–2013)— · 1 papers (2012–2012)